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Bilateral nephrectomy stopped disease progression in plasma-resistant
hemolytic uremic syndrome with neurological signs and coma. Four
women were admitted over three years because of anemia and renal
failure. They had evidence of hemotytic uremic syndrome (HUS) with
severe vascular involvement and glomerular collapse. Despite intensive
plasma exchange, all patients developed neurologic signs (with seizures
and coma in 2) and papilledema. Three developed refractory hypertension
and three required dialysis. All patients had abnormal von Willebrand
factor (vWF) fragmentation as reflected by decreased high molecular
weight and increased low molecular weight vWF multimers in the
circulation. Assuming that the disease was sustained by shear stress-
induced abnormal vWF fragmentation in damaged renal microvascula-
ture, bilateral nephrectomy was done. Surgery was followed within two
weeks by complete hematologic and clinical remission consistently asso-
ciated with the restoring of vWF fragmentation pathway to normal. We
speculate that in HUS resistant to plasma exchange or infusion, removing
the kidneys eliminates a major site of vWF fragmentation, which would
limit platelet activation and protect patients from the further spreading of
microvascular lesions.
Hemolytic uremic syndrome (HUS)—defined by rapid onset of
acute microangiopathic hemolytic anemia, thrombocytopenia,
and renal dysfunction—can still be fatal, particularly in atypical
cases of adults [1—41. Current therapies of more severe cases
include plasma infusion or exchange that effectively stop the
diseases in most instances [3—7]. However, in some 20% of adult
cases, mainly with chronic and relapsing forms, plasma manipu-
lation has no effect [1—4]. Treatment options for these unfortu-
nate patients are elusive. Aspirin and antiplatelet agents are of
little help and there are no reports on the usefulness of steroids [1,
2]. Splenectomy has seldom been used in severe HUS. It was used
with apparent success in some cases of chronic relapsing TTP, but
a recent study with a large number of patients showed an higher
mortality rate and longer disease duration in those who were
splenectomized compared to patients on plasma alone [8], Thus,
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patients with severe HUS who are plasma resistant or become
plasma dependent are essentially left with no effective treatment,
and invariably have a bad outcome.
Here we performed bilateral nephrectomy in four patients
diagnosed with severe HUS resistant to plasma. This was defined
as persistent hemolysis, relatively low platelet count, and neuro-
logical signs (including coma in two cases) which manifested
despite daily plasma exchange. Surgery was followed by prompt
normalization of platelet count and complete remission of the
disease within two weeks. Apart from their clinical implications
for the future treatment of similar cases, the present results
suggest that the renal microvasculature is a major site of periph-
eral platelet consumption in HUS, at least in the most severe
forms of the disease.
Methods
Patients
Patient 1. A 26-year-old woman who was hospitalized for
profuse vomiting, watery diarrhea and syncope, had HUS diag-
nosed on clinical and laboratory grounds (Table 1). Free fecal
neutralizable verotoxin was undetectable, but the titer of anti-
verotoxin and anti-E. coli 0.157:H7 lipopolysaccharides antibodies
was increased in the blood. At renal biopsy she had an active
microangiopathic process with vascular proliferation and thrombi,
and glomerular ischemia. Despite 50 plasma exchanges with fresh
frozen plasma infused, and 20 further plasma exchanges with
plasma cryosupernatant as the infusion fluid [7], the patient still
had thrombocytopenia, microangiopathic hemolysis persisted,
and renal function progressively deteriorated so that hemodialysis
was initiated (Table 1). High blood pressure became difficult to
control despite full doses of calcium channel blockers, beta
blockers and angiotensin converting enzyme (ACE) inhibitors.
Seizures and hypertensive encephalopathy developed with bilat-
eral retinal hemorrhages, cotton-wool spots, and papilledema
despite intravenous diazepam and nitroprusside. She underwent
bilateral nephrectomy three months after hospital admission
(Table 1). The kidneys were macroscopically normal, but histol-
ogy showed diffuse severe chronic vascular lesions associated with
signs of active microangiopathy with vascular proliferation and
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Table 1. Main clinical and laboratory findings at hospital admission and before nephrectomy
Patient No. 1 Patient No. 2 Patient No. 3 Patient No. 4
A B A B A B A B
Systolic/diastolic BP mm Hg 220/120 185/1 15 150/100 220/130 130/80 130/90 135/80 200/120
Serum creatinine mg/dl 2 74a 1.7 2.8 4.2 54a 3.2 6.6a
Hemoglobin g/dl 8.1 7.4 10.2 7.4 5.9 11.5 7.1 8.5
Hematocrit % 26 21.1 29 20.7 16.6 33 21 24
Platelet count x 100/p.! 27 100 140 129 86 128 98 117
Serum LDH lU/liter 2,200 848 1050 1682 1500 1053 794 790
Neurological signs none seizures, coma none headache, confusion none headache, confusion none seizures, coma
Abbreviations are: A, at hospital admission; B, before bilateral nephrectomy; BP, blood pressure; LDH: Lactate dehydrogenase.
aOn dialysis
thrombosis. Neurological signs subsided within 48 hours from
nephrectomy; blood pressure and platelet count returned to
normal in one week. Over two years, her blood pressure has been
persistently normal without antihypertensive medications, and she
has never had signs of recurrence of the disease. She is currently
on chronic hemodialysis and on the waiting list for a kidney
transplant.
Patient 2. A 25-year-old woman had renal failure and hyperten-
sion two weeks after an episode of watery diarrhea, fever and
macroscopic hematuria (Table 1). A renal biopsy showed findings
of thrombotic microangiopathy with severe myointimal swelling
and proliferation, luminal narrowing, thrombi of small arteries
and arterioles plus glomerular ischemia. Despite 31 between
plasma exchanges and infusions of fresh frozen plasma, renal
function deteriorated, and blood pressure remained elevated
despite beta blockers, ACE inhibitors, calcium channel blockers,
and intravenous sodium nitroprusside. Hypertensive encephalop-
athy developed with bilateral papilledema. Bilateral nephrectomy
was performed three months later (Table 1). The neurologic signs
subsided in 24 hours, and blood pressure and platelet count
became normal in seven days and antihypertensive therapy was no
longer required. After five additional months she received a
cadaveric kidney transplant. Now she is well; her serum creatinine
concentration is 1.0 mg/dl and blood pressure is normal without
medications.
Patient 3. A 26-year-old woman was originally admitted because
of severe anemia and renal failure. She had fever and upper
respiratory tract infection one month before, followed by vomiting
and gross hematuria. HUS was diagnosed on clinical grounds
(Table 1). Over three weeks of daily exchanges with two liters of
fresh frozen plasma, the serum LDH and platelet count became
normal, and serum creatinine levels decreased. However, one
week later serum LDH rose again and she developed severe
thrombocytopenia and renal failure. The patient was again given
plasma. A renal biopsy showed a diffuse chronic process of
thrombotic microangiopathy associated with signs of active arte-
riolar and glomerular lesions. In the following eight months, the
disease was consistently ameliorated by plasma, but invariably
relapsed a few weeks soon after plasma or cryosupernatant {7J was
stopped. She had a total of 110 procedures performed between
plasma exchange and infusion. Despite this, renal function con-
tinued to deteriorate and hemodialysis was necessary. The patient
became progressively confused, with headache and visual distur-
bances. Despite good blood pressure control, fundus examination
showed linear (striate) hemorrhages, cotton-wool spots, hard
exudates, and bilateral papilledema (Table 1). Computed tomog-
raphy of the brain was normal. Bilateral nephrectomy was per-
formed eight months after the first hospitalization with severe
vascular changes and glomerular lesions in the nephrectomy
specimens. After surgery, the neurologic signs subsided within two
days, and serum LDH and platelet count normalized. Vision
improved remarkably and two months later her funduscopic
examination showed only hard exudates. Now the patient is well
on chronic ambulatory peritoneal dialysis. Her blood pressure is
well controlled by low doses of calcium channel blockers and she
is on a waiting list for kidney transplantation.
Patient 4. An 11-year-old girl was admitted with fragmented
erythrocytes in the peripheral blood smear, thrombocytopenia,
high blood pressure, anemia and renal failure (Table 1) with no
evidence of previous E. coli infection. She had an active microan-
giopathic process at renal biopsy, with extensive endoluminal
thrombi in arterioles and glomeruli. Despite 22 exchanges of one
plasma volume with fresh frozen plasma or plasma cryosuperna-
tant [7], platelet count and serum LDH concentration never
normalized. Renal function progressively deteriorated and pen-
toneal dialysis was eventually needed. High blood pressure be-
came refractory to antihypertensive therapy (including beta block-
ers, ACE inhibitors and calcium channel blockers) and, despite
intravenous infusion of sodium nitroprusside, the girl developed
generalized seizures and coma (Table 1). Computerized tomog-
raphy of the brain showed diffuse ischemic lesions. Bilateral
nephrectomy was done at month four after admission. Histologic
findings were of a still active microangiopathic process with fresh
thrombi and fragmented erythrocytes in the lumina of the small
arteries, arterioles and glomerular capillaries. After surgery,
blood pressure became normal within 24 hours and the neurologic
signs subsided in seven days. Platelet count and serum LDH
normalized in few more weeks. Now, the girl is well. She has no
neurologic sequelae and her blood pressure is normal without
therapy. She is on chronic ambulatory peritoneal dialysis, and is
on the waiting list for a kidney transplant.
Renal histology
Specimens from percutaneous renal biopsy and nephrectomy
were divided into three portions for light microscopy, immuno-
fluorescence, and electron microscopy. For light microscopy, the
specimen was fixed in Dubosque-Brazil solution, embedded in
paraffin, and cut into 3-j.tm thick sections. Sections were stained
with hematoxylin and eosin, periodic acid-Schiff (PAS), Jones
silver methenamine, and Masson's trichrome. For immunofiuo-
rescence, sections of snap-frozen tissue were processed as previ-
ously described [9]. For electron microscopy studies, samples were
fixed for four hours at 4°C in 2.5% glutaraldehyde in 0.1 mol/liter
of cacodylate buffer at pH 7.4. After three washes in 0.1 mol/liter
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of cacodylate, samples were fixed in 1% osmium tetroxide for one
hour, dehydrated through ascending grades of alcohol, and em-
bedded in epon resin. Sections were cut on a LKB-V ultramic-
rotome (Leika, Wetzler, Germany) and semithin sections were
stained with toluidine blue and examined by light microscopy.
Ultrathin sections were stained with uranyl acetate and lead
citrate and examined with a Zeiss 109 electron microscope (Carl
Zeiss, Oberkochen, Germany).
vWF studies
Blood samples were taken before plasma therapy and before
and after nephrectomy as previously described [10] for the
measurement of vWF plasma antigen (vWF:Ag) and multimeric
pattern. Plasma vWF:Ag and multimeric composition were mea-
sured by sandwich ELISA and discontinuous sodium dodecylsul-
phate agarose gel electrophoresis. For vWF analysis, blood was
collected in tubes containing one tenth final volume of 110 mM
trisodium citrate as anticoagulant with 5 mM EDTA, 6 mM
N-ethylmaleimide, 1 mrvi leupeptin, and 200 kallikrein inhibitory
units (KIU) aprotinin per ml to inhibit the in vitro proteolysis.
vWF multimeric pattern was analyzed as described [11] with
minor modifications [6]. Resolving gels of 1.5% high gelling
temperature agarose HGT(P) (FMC Corp., Rockland, ME, USA)
for high molecular weight multimers resolution, or 1.4% low
gelling temperature agarose LGT(P) Type VII (Sigma, St. Louis,
MO, USA) for low molecular weight multimers resolution were
used. Other biochemical parameters were evaluated by routine
laboratory tests.
Results
Patient's clinical course
Bilateral nephrectomy was done in all of the patients due to
potentially life-threatening neurological complications. Before
deciding to remove the kidneys all of these patients were exten-
sively plasmapheresed (58 procedures on average, range 22 to
110). None of the patients ever had persistent remission of the
disease with normalization in serum LDH and platelet count for
at least two weeks before nephrectomy. Despite full doses of three
antihypertensive drugs, including an ACE inhibitor, systemic
blood pressure could not be controlled in three patients. Renal
function progressively deteriorated in all patients, and in three
cases hemodialysis was eventually needed to treat fluid overload
and uremia. At the time bilateral nephrectomy was decided, all
patients had thrombocytopenia and signs of active disease with
severe retinal and neurological involvement (Table 1). Two
patients (out of three in whom blood pressure could not be
controlled by the drugs) had generalized convulsions and coma.
Kidney specimens in all cases showed active lesions with arterial
and arteriolar involvement. Vascular lumina were diffusely re-
stricted due to myointimal proliferation. Many vessels were
completely obstructed by thrombi and fragmented erythrocytes.
Glomeruli were diffusely collapsed. In all cases the post-surgical
course was remarkably good. No patient had bleeding requiring
transfusions. Within one week after surgery blood pressure be-
came normal in all patients and the neurological signs subsided.
Complete hematological remission was achieved within two
weeks. At discharge all the patients were well and without signs of
disease activity.
vWF:Ag and multimeric pattern studies
During the acute phase of the disease vWF:Ag concentration
was higher than normal in two patients (No. 1 and 4), and within
the normal range in the other two (No. 2 and 3). Nephrectomy did
not induce significant changes in circulating vWF:Ag concentra-
tions which, before and after nephrectomy, were respectively:
patient 1, 210% and 230% (normal laboratory range 50 to 150%);
patient 2, 92% and 111%; patient 3, 136% and 159%; and patient
4, 342% and 385%. In contrast, studies on vWF multimers either
for high or low molecular weight multimers indicated important
abnormalities in the acute phase of the disease that were consis-
tent in all the four patients, and interestingly enough were
uniformly normalized by nephrectomy. Specifically, in the acute
phase of the disease before nephrectomy was performed, all
patients showed a marked reduction in the high molecular weight
multimers as compared to control plasma. As for the low molec-
ular weight multimers, they were consistently higher than normal
in the acute phase of the disease. After nephrectomy in all four
patients high molecular weight multimers were enhanced to
normal, while excessively high low molecular weight multimers
levels fell to normal. Before nephrectomy, and either before and
after plasma therapy, high molecular weight multimers were
consistently decreased in all patients, and became normal in all
cases after nephrectomy. A representative pattern of high molec-
ular weight vWF multimers before and after nephrectomy is
shown in Figure 1A. A representative pattern of low molecular
weight vWF multimers before and after nephrectomy is shown in
Figure lB.
Discussion
In these four patients plasma therapy failed to control throm-
bocytopenia and induce remission of the disease. All four had
deteriorating renal function and neurologic signs, and three were
hypertensive despite the therapy. Clinical and laboratory findings
were consistent with a progressive disease. Based on biopsy data
of extensive platelet trapping in the kidney we reasoned that
kidney microvasculature could sustain the process of platelet
consumption. If this assumption was correct, bilateral nephrec-
tomy could have improved platelet count and limited disease
progression. Admittedly this was a new procedure never reported
in the literature before, at least on the assumption that the kidney
microvasculature was the site of platelet consumption. In favor of
considering bilateral nephrectomy, there was what we believed to
be a sound scientific rationale, but against it was the lack of
previous clinical experience. The decision to remove the kidneys
in the first patient was taken by one of us at a moment this lady
was extremely ill with persistent thrombocytopenia and severe
hypertensive encephalopathy, despite multiple medications. He
judged that in such a desperate condition the patient were indeed
in imminent danger of death. In this first patient surgery was
followed by a rapid increase in platelet count, progressively less
hemolysis, and complete remission of the symptoms within one
week. When in subsequent years we had referred three similar
patients, we asked two external competent reviewers from our
hospital whether they agreed upon bilateral nephrectomy after
other therapies were unable to improve the clinical outcome.
These patients were considered to have severe neurological
involvement (with coma in 1 case), and all had progressively
deteriorating renal function that was almost certainly irreversible
qS
t
A
Remuzzi et at: Bilateral nephrectomy to cure HUS 285
B
Control Before After
nephrectomy nephrectomy
Before After
nephrectomy nephrectomy
Control
Fig. 1. A. A 1.5% HGT(P) agarose gel for the resolution of high molecular weight multimers. The origin of the gel is at the top. Arrow indicates the position
of high molecular weight multimers that are absent in patient plasma collected before nephrectomy. B. A 1.4% LGT(P) agarose gel for the resolution
of low molecular weight multimers. The origin of the gel is at the top. Arrow indicates the position of the increased band of fragmented vWF in patient
plasma collected before nephrectomy. Control is the normal plasma pooi.
(in 2 patients dialysis was necessary) according to the judgment of
our pathologist (Acknowledgments). The agreement was reached
that the approach used for the first patient could be extended to
the three additional ones, especially considering the sudden
resolution of clinical and laboratory abnormalities soon after
nephrectomy in the first lady. That this was possibly the right
decision is indirectly supported by data that after surgery, hema-
tological remission was achieved within few days in all patients
and the clinical syndrome resolved in few days. Nephrectomy also
normalized blood pressure in patients who had prior uncontrolled
hypertension, and the case with retinal changes despite normo-
tension also had her fundus normalized. Despite the fact that the
gross appearance of the nephrectomized kidneys was almost
normal in all cases, microscopy invariably showed findings of
severe chronic microvascular involvement associated with a still
active disease process. This was taken to suggest that platelets
indeed continued to be consumed in the microvasculature of the
kidneys, and that neurological and ocular changes occurred as
secondary processes. The clinical course of these patients helps to
clarify the mechanisms of disease progression in cases of severe
HUS refractory to plasma manipulation.
A consensus has built up in the last few years that vascular
endothelial damage initiates events eventually leading to organ
dysfunction [2]. Cases in which the initial insult is self-limiting,
such those triggered by verotoxin-producing Escherichia coli or
other bacteria [1], mostly recover renal function in few weeks. In
atypical HUS, extensive structural damage of microvessels asso-
ciated with narrowing of the lumina may determine major changes
in fluid shear stress, which would favor persistent endothelial
damage and progression of microvascular lesions. Recent data
have indeed convincingly established that shear stress by modu-
lating intracellular signaling [12] influences endothelial protein
synthesis and regulates cell proliferation [13, 14]. Other studies
have also found a direct link between shear stress and vWF
handling. Thus, shear stress causes vWF cleavage and fragmenta-
tion in vitro [15], and data are also available that fragmented vWF
binds avidly to receptors on activated platelets [16]. Here we
found abnormal vWF fragmentation, reflected by an increase in
low molecular weight vWF multimers, during the acute phase of
the disease. Bilateral nephrectomy was followed by hematologic
and clinical remission consistently associated with restoring of
vWF fragmentation pathway to normal (Fig. 1). We speculate that
in cases of severe HUS resistant to plasma manipulation, remov-
ing the kidneys eliminates a major site of vWF fragmentation
which would limit platelet activation and inhibit further spreading
of microvascular lesions (Fig. 2).
However, because bilateral nephrectomy is an irreversible
maneuver, we would recommend considering this as a rescue
procedure only for those very patients in whom other approaches
have failed. We would also like to suggest some practical guide-
lines to an appropriate use of nephrectomy. Potential candidates
are patients who are plasma-resistant (that is, > 20 procedures
with no improvement of clinical and laboratory findings) or
plasma-dependent (patients who have to be continuously infused
with plasma to remain in remission, and in whom the platelet
count invariably decreases with signs of hemolysis within few days
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Fig. 2. Scheme of the events supposed to lead to diffuse vascular thrombosis and neurological involvement in atypical HUS resistant to plasma therapy.
after plasma is discontinued). Nephrectomy should not be con-
sidered unless a renal biopsy—taken as soon as the platelet count
increases with plasma, even transiently, to a point that the
procedure is safe—shows chronic diffuse lesions associated with
signs of the disease, that is, arteriolar thrombosis and myointimal
proliferation. Finally, we advise that nephrectomy is considered
only in the presence of life-threatening signs such as major
neurological dysfunction or coma (as in the present cases) or
uncontrolled bleeding as a consequence of refractory thrombocy-
topenia.
A final further word of caution: as for the old times of
Goodpasture's syndrome in which bilateral nephrectomy gave
initially excellent results on pulmonary hemorrhage [17, 181 but
disappointing responses in some subsequent cases [19], we will not
be surprised if nephrectomy may fail in some future grave case of
HUS. However, when more conventional therapies do not im-
prove the outcome, nephrologists should be aware of the fact that
nephrectomy may cure the disease.
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